Palvella Therapeutics, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
Palvella Therapeutics, Inc. (PVLA) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2024-11-13
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-09-30 was $0.00.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-06-30 was $0.00.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was -$100.00K, a 125.00% decline from fiscal 2022.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $400.00K.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2021 was $0.00.
- Palvella Therapeutics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2020 was -$600.00K, a 300.00% decline from fiscal 2019.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month as first filed | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month as first filed | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | -$100.00K 10-K · filed 2024-03-29 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | -$100.00K 10-Q · filed 2024-11-13 | $200.00K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | $100.00K 10-Q · filed 2024-08-14 | -$100.00K 10-Q · filed 2023-08-10 | $200.00K derived: sum of 3 quarters · filed 2024-08-14 | $400.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-15 | -$100.00K 10-Q · filed 2023-05-11 | $200.00K derived: sum of 2 quarters · filed 2024-05-15 | $400.00K derived: sum of 3 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $300.00K derived: sum of 2 quarters · filed 2024-03-29 | $400.00K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-14 | $300.00K 10-Q · filed 2023-11-14 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $0.00 derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | -$600.00K derived: sum of 4 quarters · filed 2022-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | -$600.00K derived: sum of 3 quarters · filed 2022-05-11 | -$800.00K derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | -$600.00K derived: sum of 2 quarters · filed 2022-05-11 | -$800.00K derived: sum of 3 quarters · filed 2022-05-11 | -$800.00K derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | -$800.00K derived: sum of 2 quarters · filed 2022-03-02 | -$800.00K derived: sum of 3 quarters · filed 2022-03-02 | -$600.00K 10-K · filed 2022-03-02 | ||
| 2020-09-30 | -$200.00K 10-Q · filed 2021-11-02 | -$200.00K derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | $100.00K derived: sum of 4 quarters · filed 2021-11-02 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $200.00K 10-Q · filed 2021-08-05 | $300.00K derived: sum of 3 quarters · filed 2021-08-05 | $400.00K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-17 | $300.00K derived: sum of 2 quarters · filed 2021-05-17 | $400.00K derived: sum of 3 quarters · filed 2021-05-17 | $500.00K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $200.00K derived: sum of 2 quarters · filed 2021-03-31 | $300.00K derived: sum of 3 quarters · filed 2021-03-31 | $300.00K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-04 | $200.00K derived: sum of 2 quarters · filed 2020-11-04 | $200.00K 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-10 | $100.00K 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | |||||
| 2018-09-30 | $800.00K 10-Q · filed 2019-11-12 | $900.00K derived: sum of 2 quarters · filed 2019-11-12 | -$700.00K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $100.00K 10-Q · filed 2019-08-09 | -$100.00K 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | -$200.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |